Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 80,618 | 122,715 | 175,761 | 94,307 | 63,324 |
| Marketable Securities | 106,876 | 67,893 | 24,963 | 43,901 | 82,253 |
| Receivables | 7,424 | 12,660 | 11,159 | 7,808 | 29,440 |
| Inventories | 23,425 | 21,599 | 14,621 | 19,916 | 13,223 |
| Other current assets | 0 | 7,656 | 0 | 0 | 0 |
| TOTAL | $231,500 | $243,060 | $241,815 | $179,938 | $198,757 |
| Non-Current Assets | |||||
| PPE Net | 1,393 | 1,658 | 1,995 | 2,150 | 2,475 |
| Intangibles | 18,000 | 18,250 | 18,500 | 18,750 | 19,000 |
| Other Non-Current Assets | 191,969 | 196,704 | 197,643 | 9,738 | 10,733 |
| TOTAL | $211,362 | $216,612 | $218,138 | $30,638 | $32,208 |
| Total Assets | $442,862 | $459,672 | $459,953 | $210,576 | $230,965 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,391 | 7,899 | 1,469 | 2,522 | 3,383 |
| Accrued Expenses | 20,885 | 30,112 | 30,868 | 34,500 | 38,887 |
| Other current liabilities | 4,334 | 5,754 | 8,789 | 3,186 | 4,773 |
| TOTAL | $36,587 | $47,066 | $56,492 | $43,544 | $50,354 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 6,495 | N/A | 12,092 | N/A | N/A |
| Other Non-Current Liabilities | 4,017 | 4,457 | 5,255 | 1,538 | 2,367 |
| TOTAL | $16,180 | $16,457 | $19,453 | $13,538 | $14,367 |
| Total Liabilities | $52,767 | $63,523 | $75,945 | $57,082 | $64,721 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 69,900 | 69,753 | 69,532 | 69,471 | 69,276 |
| Common Shares | 19 | 19 | 19 | 19 | 19 |
| Retained earnings | -504,304 | -492,034 | -496,495 | -720,588 | -700,607 |
| Other shareholders' equity | 55 | 44 | -70 | -90 | -103 |
| TOTAL | $390,095 | $396,149 | $384,008 | $153,494 | $166,244 |
| Total Liabilities And Equity | $442,862 | $459,672 | $459,953 | $210,576 | $230,965 |